Trifunctional antibodies, binding to the natural killer cell receptors NKp46 and CD16, as well as a tumour antigen, show promising activity in preclinical experiments.
CITATION STYLE
Flemming, A. (2019, July 1). Trifunctional antibodies unleash NK cells. Nature Reviews Cancer. Nature Publishing Group. https://doi.org/10.1038/s41568-019-0166-0
Mendeley helps you to discover research relevant for your work.